Stock Events

Stock Events

Filana Therapeutics (SAVA) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.92

-0.68

-0.45

-0.21

Details

Expected EPS

-0.23

Actual EPS

-0.21

Surprise EPS

0.02

Surprise Percent

+8.7%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.21 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.